You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-11:  Trends in prevalence of markers of HBV infection estimated from national and sub-national samples of injecting drug users 1995 to 2004, where data are available – Part (i) Injecting drug users aHBc positive (ever infected)

Figure INF-11 part i

inffig11a-en.swf

Notes:

Seroprevalence studies (SP) data from diagnostic testing (DT).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national focal points.

Data filter | inffig11a-en.xml